Supplementary Table S2 from Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol
Year: 2025
Type: supplementary-materials
Abstract: Representativeness of study population
Authors: Karlijn Verkerk, Soemeya F. Haj Mohammad, Laurien J. Zeverijn, Birgit S. Geurts, Ilse A.C. Spiekman, Florentine A.J. Verbeek, Hans Timmer, Maud A. van Maren, V. van der Noort, Miguel Parra-Martinez, Paul Roepman, Anne M.L. Jansen, Wendy W.J. de Leng, Serena Marchetti, Kim Monkhorst, Henk M.W. Verheul, Hans Gelderblom, Emile E. Voest
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4416843930